METASTATIC HORMONE RECEPTOR POSITIVE BREAST CANCER
Clinical trials for METASTATIC HORMONE RECEPTOR POSITIVE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC HORMONE RECEPTOR POSITIVE BREAST CANCER trials appear
Sign up with your email to follow new studies for METASTATIC HORMONE RECEPTOR POSITIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Dual-Action drug targets Hard-to-Treat breast cancer
Disease control Recruiting nowThis early-stage study tests two related drugs in people with advanced hormone-receptor positive breast cancer that has spread or come back. The first drug (68Ga-R11228) helps doctors see tumors on a PET scan. The second drug (177Lu-R11228) delivers targeted radiation to kill can…
Matched conditions: METASTATIC HORMONE RECEPTOR POSITIVE BREAST CANCER
Phase: PHASE1 • Sponsor: Radionetics Oncology • Aim: Disease control
Last updated May 04, 2026 16:22 UTC
-
New PET tracer aims to light up Hard-to-Find breast cancer spots
Diagnosis Recruiting nowThis early-phase study tests a new radioactive imaging agent called 68Ga-R10602 to see if it can find tumors in people with hormone receptor-positive breast cancer that has spread or come back. About 36 adults whose cancer no longer responds to hormone therapy will receive the ag…
Matched conditions: METASTATIC HORMONE RECEPTOR POSITIVE BREAST CANCER
Phase: PHASE1 • Sponsor: Radionetics Oncology • Aim: Diagnosis
Last updated May 07, 2026 18:40 UTC